Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 3 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Telangiectasis 1 Skin Neoplasms 1 Rosacea 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Port-Wine Stain 1 Pancreatic Neoplasms 1 Pancreatic Intraductal Neoplasms 1 Non-melanoma Skin Cancer 1 Nevus, Pigmented 1 Nasopharyngeal Neoplasms 1 Mixed Tumor, Malignant 1 Melanoma 1 Lung Neoplasms 1 Keratosis, Seborrheic 1 Keratosis 1 Hemangioma 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Barrett Esophagus 1

Interventions

pembrolizumab 3 Ipilimumab 3 Educational Status 3 Biopsy 3 Optical Imaging 2 Nivolumab 2 Early Intervention, Educational 2 Ascorbic Acid 2 methyl 5-aminolevulinate 1 lavender oil 1 four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate) 1 fludarabine phosphate 1 fludarabine 1 aldesleukin 1 Zinc 1 Water 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Tomography, Optical Coherence 1 Toll-Like Receptor 1 1 Tea 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Spermine Synthase 1 Specimen Handling 1 Semaxinib 1 Second Harmonic Generation Microscopy 1 Risk Factors 1 Resistance Training 1 Radiotherapy, Image-Guided 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Skin Neoplasms × Tomography, Optical Coherence × Clear all

NCT01662713 2023-03-15

OFDI

Massachusetts General Hospital

Phase NA Completed

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡